Apis Capital Advisors’s Aspen Aerogels ASPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-89,600
Closed -$885K 26
2022
Q2
$885K Buy
+89,600
New +$1.81M 1% 24
2021
Q3
Sell
-45,000
Closed -$1.35M 38
2021
Q2
$1.35M Buy
+45,000
New +$918K 1.16% 23

Other funds holding ASPN

Apis Capital Advisors's ASPN Position: Q3 2022 in Review

Apis Capital Advisors sold out of Aspen Aerogels (ASPN) in Q3 2022, closing a stake of 89,600 shares — an estimated $885K sold.

Apis Capital Advisors first reported a position in ASPN in Q2 2021 and held it in 2 quarters. The position peaked at $1.35M in Q2 2021. 139 funds tracked by Wall St. Rank hold ASPN as of Q3 2022.

  • Apis Capital Advisors reported no remaining Aspen Aerogels position as of Q3 2022 after selling out during the quarter.
  • Apis Capital Advisors sold 89,600 Aspen Aerogels shares in Q3 2022, an estimated $885K.
  • Apis Capital Advisors first reported a position in Aspen Aerogels in Q2 2021 and held it in 2 quarters.
  • Apis Capital Advisors's Aspen Aerogels position peaked at $1.35M in Q2 2021.
  • 139 funds tracked by Wall St. Rank held Aspen Aerogels as of Q3 2022.

Based on Apis Capital Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.